Glut9-mediated Urate Uptake Is Responsible for Its Protective Effects on Dopaminergic Neurons in Parkinson's Disease Models.
Glut9-mediated Urate Uptake Is Responsible for Its Protective Effects on Dopaminergic Neurons in Parkinson's Disease Models.
复制标题
Glut9 介导的尿酸盐摄取对帕金森病模型中的多巴胺能神经元具有保护作用
DOI:
10.3389/fnmol.2018.00021
复制
发表时间:
2018
影响因子:
4.8
通讯作者:
Jiang H
中科院分区:
文献类型:
--
作者:
Bi M;Jiao Q;Du X;Jiang H
Considerable evidence has shown that elevated plasma or cerebrospinal fluid (CSF) urate levels correlated with a reduced risk of Parkinson’s disease (PD). Based on its anti-oxidative properties, urate might serve as one of promising neuroprotective candidates for PD. However, how urate is transported through cell membranes to exert its effects inside the cells in PD is largely unknown. To elucidate this, we showed that increased intracellular urate exerted its neuroprotective effects against 1-methyl-4-phenylpyridinium (MPP+)-induced neurotoxicity in MES23.5 cells and elevated urate could antagonize 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced nigral dopaminergic neuronal death in urate oxidase (UOx) knockout (KO) mice. Its transporter, glucose transporter type 9 (Glut9), was observed up-regulated, which was caused by the activation of p53. These protective effects could be abolished by Glut9 blocker and p53 inhibitor. These results suggested that Glut9 was a functional urate transporter, whose up-regulation by activation of p53 resulted in the increased intracellular urate levels in PD models. Our findings suggest that Glut9 could be modified to modulate urate levels in dopaminergic neurons and urate-elevating strategies without increasing systemic levels to avoid side effects might serve as a potential therapeutic target for PD.
登录
查看更多内容
DOI:
10.1073/pnas.78.11.6858
发表时间:
1981-01-01
期刊:
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES
影响因子:
--
作者:
AMES, BN;CATHCART, R;HOCHSTEIN, P
通讯作者:
HOCHSTEIN, P
影响因子:
4.7
作者:
Gong, Li;Zhang, Qi-Lin;Luo, Wei-Feng
通讯作者:
Luo, Wei-Feng
影响因子:
6.1
作者:
Bakshi R;Zhang H;Logan R;Joshi I;Xu Y;Chen X;Schwarzschild MA
通讯作者:
Schwarzschild MA
DOI:
10.3233/jad-2010-1330
发表时间:
2010
期刊:
Journal of Alzheimer's disease : JAD
影响因子:
--
作者:
Bowman GL;Shannon J;Frei B;Kaye JA;Quinn JF
通讯作者:
Quinn JF
影响因子:
3.1
作者:
Facheris, Maurizio F.;Hicks, Andrew A.;Pramstaller, Peter P.
通讯作者:
Pramstaller, Peter P.